Clinical Trial Update: Insulin Glulisine in Type 1 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating insulin glulisine for Type 1 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Apidra (insulin glulisine)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED